NCT02544633
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02544633 |
| Title | Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Mirati Therapeutics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | POL | ITA | HUN | GBR | CAN | AUS |
CKB BOOST